Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Evaluating COVID-19-Related Disruptions to Effective Malaria Case Management in 2020–2021 and Its Potential Effects on Malaria Burden in Sub-Saharan Africa
Tropical Medicine and Infectious Disease, Volume 8, No. 4, Article 216, Year 2023
Notification
URL copied to clipboard!
Description
The COVID-19 pandemic has led to far-reaching disruptions to health systems, including preventative and curative services for malaria. The aim of this study was to estimate the magnitude of disruptions in malaria case management in sub-Saharan Africa and their impact on malaria burden during the COVID-19 pandemic. We used survey data collected by the World Health Organization, in which individual country stakeholders reported on the extent of disruptions to malaria diagnosis and treatment. The relative disruption values were then applied to estimates of antimalarial treatment rates and used as inputs to an established spatiotemporal Bayesian geostatistical framework to generate annual malaria burden estimates with case management disruptions. This enabled an estimation of the additional malaria burden attributable to pandemic-related impacts on treatment rates in 2020 and 2021. Our analysis found that disruptions in access to antimalarial treatment in sub-Saharan Africa likely resulted in approximately 5.9 (4.4–7.2 95% CI) million more malaria cases and 76 (20–132) thousand additional deaths in the 2020–2021 period within the study region, equivalent to approximately 1.2% (0.3–2.1 95% CI) greater clinical incidence of malaria and 8.1% (2.1–14.1 95% CI) greater malaria mortality than expected in the absence of the disruptions to malaria case management. The available evidence suggests that access to antimalarials was disrupted to a significant degree and should be considered an area of focus to avoid further escalations in malaria morbidity and mortality. The results from this analysis were used to estimate cases and deaths in the World Malaria Report 2022 during the pandemic years. © 2023 by the authors.
Authors & Co-Authors
Rumisha, Susan Fred
Australia, Perth
Telethon Kids Institute
Lubinda, Jailos
Australia, Perth
Telethon Kids Institute
Saddler, Adam
Australia, Perth
Telethon Kids Institute
Assefa, Yalemzewod Assefa
Australia, Perth
Telethon Kids Institute
Harris, Joseph R.
Australia, Perth
Telethon Kids Institute
Browne, Annie J.
Australia, Perth
Telethon Kids Institute
Rozier, Jennifer A.
Australia, Perth
Telethon Kids Institute
Galatas, Beatriz
Switzerland, Geneva
Organisation Mondiale de la Santé
Anderson, Laura Fay
Switzerland, Geneva
Organisation Mondiale de la Santé
Vargas-Ruiz, Camilo A.
Australia, Perth
Telethon Kids Institute
Australia, Perth
Curtin University
Cameron, Ewan
Australia, Perth
Telethon Kids Institute
Australia, Perth
Curtin University
Gething, Peter W.
Australia, Perth
Telethon Kids Institute
Australia, Perth
Curtin University
Weiss, Daniel J.
Australia, Perth
Telethon Kids Institute
Australia, Perth
Curtin University
Statistics
Authors: 13
Affiliations: 3
Identifiers
Doi:
10.3390/tropicalmed8040216
ISSN:
24146366
Research Areas
Covid
Health System And Policy
Infectious Diseases
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative